newsfilter
← Latest News
ClinicalTrials.gov·

Varian ProBeam Proton Therapy System China Clinical Trial (Hefei) - NCT05463055

tumor disease control rate reaches the objective performance criteria (80%), CTCAE level 3 toxic reaction ratio is lower than the acceptable value (5%), CTCAE level 4 and 5 toxic reaction ratio is acceptable value (0%), (and 8 more...)